IQVIA Holdings
Open
$158.75
Prev. Close
$158.79
High
$158.85
Low
$158.75
Market Snapshot
$26.63B
19.6
7.57
$15.41B
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 93,000 full-time employees. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
emptyResult
IQVIA Holdings, Inc. engages in the provision of analytics, technology solutions, and clinical research services to the life sciences industry. The company is headquartered in Durham, North Carolina and currently employs 93,000 full-time employees. The company went IPO on 2013-05-09. Its segments include Technology & Analytics Solutions, Research & Development Solutions and Contract Sales & Medical Solutions. The Technology & Analytics Solutions segment provides mission-critical information, technology solutions and real-world insights and services to the Company’s life science clients. The Research & Development Solutions segment primarily serves biopharmaceutical customers, and provides outsourced clinical research and clinical trial-related services. The Contract Sales & Medical Solutions segment provides healthcare provider (including contract sales) and patient engagement services to both biopharmaceutical customers and the broader healthcare market. The company offers a set of strategic and implementation consulting services, including advanced analytics and commercial processes outsourcing services.
Recently from Cashu
Charles River Laboratories Initiates Divestiture for Enhanced Operational Focus and Growth
Charles River Laboratories Initiates Strategic Divestiture to Enhance Core Operations Charles River Laboratories, a key player in the biotechnology and pharmaceutical sectors, announces a significant…
Charles River Laboratories Restructures for Enhanced Focus and Growth
Charles River Laboratories Restructures for Core Focus and Growth In a significant strategic realignment, Charles River Laboratories (NYSE: CRL) announces its plan to divest certain segments of its bu…
IQVIA Holdings: Leading the AI Revolution with Practical Healthcare Applications
AI Revolution: A Shift Toward Practical Applications As the artificial intelligence (AI) landscape undergoes significant transformation, IQVIA Holdings finds itself at the forefront of this evolution.…
IQVIA Holdings: Analysts Upgrade Signals Strong Growth Potential in Health Data Solutions
IQVIA’s Growth Trajectory: Analysts Recognize Potential in Health Data Solutions In recent developments within the healthcare analytics sector, IQVIA Holdings garners attention as Baird upgrades its r…